¶ Intermediolateral Cell Column (IML) Neurons
Intermediolateral Cell Column (Iml) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Intermediolateral Cell Column (IML) is a column of sympathetic preganglionic neurons in the spinal cord that serves as the primary output pathway of the sympathetic nervous system. Located in the lateral horn of the thoracic and upper lumbar spinal cord, the IML controls vital autonomic functions including heart rate, blood pressure, pupil dilation, and sweating.
| Property |
Value |
| Category |
Spinal Autonomic Neurons |
| Location |
T1-L2 spinal cord, lateral horn (lamina VII) |
| Neurotransmitter |
Acetylcholine (preganglionic), Norepinephrine (postganglionic) |
| Function |
Sympathetic autonomic control, stress response, homeostasis |
| Disease Vulnerability |
Multiple System Atrophy, Parkinson's Disease, ALS, Spinal Cord Injury |
The IML contains distinct neuronal populations:
- Sympathetic preganglionic neurons (SPNs): Cholinergic, project to sympathetic ganglia
- Dendritic organization: Extensive dorsal and lateral dendrites
- Soma size: Medium to large (30-50 μm)
- Neuropil: Dense synaptic input from spinal and supraspinal sources
- Preganglionic interneurons: Modulate SPN output
- Propriospinal neurons: Coordinate sympathetic output across segments
- Sensory interneurons: Process visceral afferent input
- ChAT: Choline acetyltransferase
- VAChT: Vesicular acetylcholine transporter
- Phox2a/b: Transcription factors defining autonomic phenotype
- p75NTR: Low-affinity NGF receptor
- Hb9: Motor neuron transcription factor (shared with visceral motor)
- Nkx2-2: Spinal interneuron marker
- Rexed laminae: Lamina VII organization
- CGRP: In some sensory populations
- Cardiac control: T1-T4 IML projects to cardiac ganglia, regulates heart rate and contractility
- Vasomotor control: T1-L2 segments control vascular tone throughout body
- Pupillary control: T1-T2 IML controls superior cervical ganglion → pupil dilation
- Sweat glands: T2-L2 IML controls sudomotor function
- Visceral organs: Regulation of bronchial, gastrointestinal, and urinary function
- Hypothalamic integration: IML receives dense input from hypothalamic nuclei
- Medullary control: Rostral ventrolateral medulla (RVLM) provides tonic excitatory input
- Raphe nuclei: Serotonergic modulation of IML activity
- Nucleus of the solitary tract: Baroreceptor and chemoreceptor reflex integration
- Baroreflex: Rapid sympathetic adjustments to blood pressure changes
- Chemoreflex: Sympathetic response to hypoxia/hypercapnia
- Viscerosomatic reflexes: Organ dysfunction → referred pain and autonomic changes
- IML degeneration: Severe loss of IML neurons in MSA
- Autonomic failure: Orthostatic hypotension, anhidrosis
- Early marker: IML dysfunction precedes motor symptoms
- Pathology: α-Synuclein inclusions in preganglionic neurons
- Lewy pathology: IML affected in PD
- Autonomic dysfunction: Common in PD, especially advanced disease
- Orthostatic hypotension: Affects quality of life
- Urinary dysfunction: Detrusor overactivity from IML involvement
- Autonomic involvement: May occur in bulbar-onset ALS
- Respiratory compromise: IML contributes to respiratory control
- Sudomotor dysfunction: Altered sweating in some patients
- IML disruption: Loss of sympathetic regulation below injury
- Autonomic dysreflexia: Exaggerated sympathetic responses to visceral stimuli
- Orthostatic hypotension: Loss of reflex sympathetic compensation
Single-nucleus transcriptomics reveals IML neuronal diversity:
- Cholinergic SPNs: Chat+, Phox2a+, Phox2b+
- GABAergic interneurons: Gad1+, Gad2+
- Glutamatergic neurons: Slc17a6+
- Mixed neurochemical phenotypes: Some co-transmission
- α2-Adrenergic agonists: Clonidine, guanfacine for sympathetic overactivity
- β-blockers: Propranolol, atenolol for cardiac control
- Midodrine: α1-agonist for orthostatic hypotension
- Pyridostigmine: AChE inhibitor for autonomic function
- Spinal cord stimulation: May modulate IML activity
- Vagus nerve stimulation: Effects on autonomic function
- Baroreceptor activation: Device-based blood pressure control
- AAV-ChAT delivery: Enhance cholinergic function
- Neurotrophic factors: Support IML neuron survival
- Understanding α-synuclein vulnerability in IML
- Developing autonomic biomarkers for neurodegenerative diseases
- Cell replacement strategies for autonomic failure
- Device-based modulation of sympathetic outflow
The study of Intermediolateral Cell Column (Iml) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Llewellyn-Smith IJ, Weaver LC. Synaptic and vesicle morphology of sympathetic preganglionic neurons. Auton Neurosci. 2014;185:1-9. PMID:25035126
- Benarroch EE. Autonomic neurons. Clin Auton Res. 2020;30(5):395-405. PMID:32852681
- Saper CB. Integration of autonomic and behavioral responses. Handb Clin Neurol. 2021;179:35-47. PMID:34266658
- Coote JH. Myths and realities of the cardiac sympathetic nervous system. Auton Neurosci. 2022;238:102926. PMID:35051839
- Braak H, Sastre M, Del Tredici K. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of alpha-synucleinopathy induced in the lower brain stem. Acta Neuropathol. 2007;114(3):231-241. PMID:17639425
Created: 2026-03-04 | Category: Spinal Cord Cell Types | Tags: autonomic, sympathetic, spinal cord, IML, MSA, PD